Abbott Laboratories (ABT)
NYSE · Healthcare
Abbott Laboratories Total Liabilities 2007–2025
Abbott Laboratories annual total liabilities history from 2007 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Abbott Laboratories total liabilities as of December 31, 2025: 34.58B, a 2.47% increase year-over-year.
- Abbott Laboratories total liabilities for 2025 were 34.58B, a 2.47% increase from 2024.
- Abbott Laboratories total liabilities for 2024 were 33.75B, a 2.49% decrease from 2023.
- Abbott Laboratories total liabilities for 2023 were 34.61B, a 8.32% decrease from 2022.
- Abbott Laboratories total liabilities for 2022 were 37.75B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Abbott Laboratories Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $34,583 |
| 2024 | $33,750 |
| 2023 | $34,611 |
| 2022 | $37,752 |
| 2021 | $39,394 |
| 2020 | $39,764 |
| 2019 | $36,799 |
| 2018 | $36,649 |
| 2017 | $45,353 |
| 2016 | $32,128 |
| 2015 | $20,036 |
| 2014 | $19,681 |
| 2013 | $17,766 |
| 2012 | $40,514 |
| 2011 | $35,837 |
Abbott Laboratories Total Liabilities — FAQ
Abbott Laboratories (ABT) total liabilities over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABT's total liabilities history?
The chart and table above show Abbott Laboratories's total liabilities by year and by quarter, including the growth rate.